Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Reindl

Showing results (91-100 of 248) with videos related to

Pageof 25
Sort By:
Journal of Neuroimmunology|February 15, 2011
Temporal dynamics of cerebrospinal fluid anti-aquaporin-4 antibodies in patients with neuromyelitis optica spectrum disordersIrena Dujmovic, Simone Mader, Kathrin Schanda, et al.
Malaria Journal|March 3, 2009
Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot studyPeter Lackner, Andrea Part, Christoph Burger, et al.
Neurocritical Care|March 8, 2011
Endovascular cooling and endothelial activation in hemorrhagic stroke patientsMarlene Fischer, Anelia Dietmann, Peter Lackner, et al.
The New England Journal of Medicine|July 19, 2002
Toll-like receptor 4 polymorphisms and atherogenesisStefan Kiechl, Eva Lorenz, Markus Reindl, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 27, 2013
No evidence for a role of rare CYP27B1 variants in Austrian multiple sclerosis patientsEva Reinthaler, Gerrit Machetanz, Christoph Hotzy, et al.
The Journal of Allergy and Clinical Immunology|January 30, 2022
Comparative analyses of IgG/IgA neutralizing effects induced by three COVID-19 vaccines against variants of concernEliott Lafon, Michael Jäger, Angelika Bauer, et al.
BMC Neurology|November 17, 2022
Anti-NMDA receptor encephalitis and MOG-associated demyelination - a case report with long-term follow-up and a systematic reviewKlaus Berek, Astrid Grams, Christian Uprimny, et al.
The New England Journal of Medicine|July 11, 2003
Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating eventThomas Berger, Paul Rubner, Franz Schautzer, et al.
Journal of Neuroimmunology|March 7, 2006
Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatmentsMichael Khalil, Markus Reindl, Andreas Lutterotti, et al.
Plos One|July 9, 2016
Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational StudyGabriel Bsteh, Rainer Ehling, Andreas Lutterotti, et al.
Pageof 25

Showing results (91-100 of 248) with videos related to

Sort By:
Pageof 25
Journal of Neuroimmunology|February 15, 2011
Temporal dynamics of cerebrospinal fluid anti-aquaporin-4 antibodies in patients with neuromyelitis optica spectrum disordersIrena Dujmovic, Simone Mader, Kathrin Schanda, et al.
Malaria Journal|March 3, 2009
Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot studyPeter Lackner, Andrea Part, Christoph Burger, et al.
Neurocritical Care|March 8, 2011
Endovascular cooling and endothelial activation in hemorrhagic stroke patientsMarlene Fischer, Anelia Dietmann, Peter Lackner, et al.
The New England Journal of Medicine|July 19, 2002
Toll-like receptor 4 polymorphisms and atherogenesisStefan Kiechl, Eva Lorenz, Markus Reindl, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 27, 2013
No evidence for a role of rare CYP27B1 variants in Austrian multiple sclerosis patientsEva Reinthaler, Gerrit Machetanz, Christoph Hotzy, et al.
The Journal of Allergy and Clinical Immunology|January 30, 2022
Comparative analyses of IgG/IgA neutralizing effects induced by three COVID-19 vaccines against variants of concernEliott Lafon, Michael Jäger, Angelika Bauer, et al.
BMC Neurology|November 17, 2022
Anti-NMDA receptor encephalitis and MOG-associated demyelination - a case report with long-term follow-up and a systematic reviewKlaus Berek, Astrid Grams, Christian Uprimny, et al.
The New England Journal of Medicine|July 11, 2003
Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating eventThomas Berger, Paul Rubner, Franz Schautzer, et al.
Journal of Neuroimmunology|March 7, 2006
Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatmentsMichael Khalil, Markus Reindl, Andreas Lutterotti, et al.
Plos One|July 9, 2016
Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational StudyGabriel Bsteh, Rainer Ehling, Andreas Lutterotti, et al.
Pageof 25